Skip to main content

Table 1 Average prostate cancer detection tests nationally 2015–2019 and tests in 2020

From: The effect of COVID-19 on prostate cancer testing in Australia

 

Average 2015–2019 (95%CI)

2020

Difference (95%CI; and % of average)

Significance

PSA tests

678,082 (660,114 to 704,283)

657,687

− 20,395 (− 41,991 to 1200; 97)

P = 0.059 (t = 2.62)

Prostate MRI

34,368a

34,061

− 307 (†; 99)

N/A†

Prostate biopsies

19,573 (18,285 to 20,980)

20,463

 + 890 (314–2094; 105)

P = 0.109 (t = − 2.05)

  1. Statistical analysis not possible owing to limited data set
  2. aFull year data only available for 2019–2020